Cyclic GMP and myosin II combine in a novel way to protect Dictyostelium cells from changes in external osmolarity. A newly discovered homologue of bacterial histidine kinases is also required for resistance to osmotic shock and may be a part of the same system. The second messenger cyclic GMP (cGMP) is a biological enigma. Chemically, it is very similar to cyclic AMP, a signalling molecule whose functions are well understood and well conserved throughout eukaryotes. The role of cGMP is much less clear, however, and varies remarkably between cell types. A recent report [1] reveals a novel and unexpected function for cGMP, in promoting resistance to osmotic shock in Dictyostelium.
The second messenger cyclic GMP (cGMP) is a biological enigma. Chemically, it is very similar to cyclic AMP, a signalling molecule whose functions are well understood and well conserved throughout eukaryotes. The role of cGMP is much less clear, however, and varies remarkably between cell types. A recent report [1] reveals a novel and unexpected function for cGMP, in promoting resistance to osmotic shock in Dictyostelium.
A message with many meanings
Signalling through cGMP is central to a broad range of processes including vertebrate light detection, hormonal control of smooth muscle tone, changes in the behaviour of invertebrate sperm in response to eggs, and chemotaxis and motility in Dictyostelium amoebae. Levels of cGMP are modulated by a different pathway in each of these cases. In mammalian photoreceptor cells, light causes a transient dip in cGMP levels by activating a cGMP phosphodiesterase. Invertebrate sperm detect egg-derived peptides using receptor guanylyl cyclases, which couple ligand binding to intracellular cGMP synthesis through a single transmembrane domain; similar receptors mediate the action of a number of mammalian hormones, including atrial natriuretic peptide. Smooth muscle contraction has recently (and intriguingly) been demonstrated to respond to reactive, gaseous messengers such as nitric oxide (NO) and, possibly, carbon monoxide (CO). NO and CO stimulate cGMP production by binding to the haem group of a soluble guanylyl cyclase. Finally, when Dictyostelium cells are stimulated by chemoattractants, intracellular cGMP increases briefly up to ten-fold as a result of stimulation of a soluble cyclase -but this particular enzyme is stimulated through G protein pathways, not by gases (NO has recently been shown to cause ADP-ribosylation of Dictyostelium proteins, but without affecting cGMP levels).
The role of cGMP in Dictyostelium movement
The best-understood function of cGMP in Dictyostelium is in the control of myosin II, the conventional two-headed myosin made up of two heavy and four light chains. The peak in cGMP levels that follows a sudden stimulation by chemoattractants lasts for less than a minute and correlates with a cell rounding and loss of direction which has been described as a 'cringe'. Evidence that the cringe is directly caused by cGMP comes from the streamer F mutant (stmF), which shows a greatly extended cGMP peak, apparently as a result of a mutation in the gene for cGMP phosphodiesterase, and which also exhibits a comparably extended cringe [2] . During the cringe, myosin II becomes phosphorylated on both heavy and light chains. The heavy chain phosphorylation is associated with destabilization of existing filaments, and could therefore allow myosin II to mobilize and relocalize, whereas the light chain phosphorylation causes activation of the myosin motor. Again, mutations which alter cGMP levels also alter both types of myosin II phosphorylation. In stmF mutants, the peak in phosphorylation is delayed, and in KI-10, a mutant which cannot activate guanylyl cyclase, chemoattractants do not alter myosin II phosphorylation [3] . Thus, cGMP seems to have two effects: it causes the redistribution of myosin II and also activates it. The cringe probably reflects a non-physiological, undirected squeeze in cells which are being equally stimulated all over their surfaces -there is no evidence that it happens during normal chemotaxis up a gradient.
Unfortunately, this picture, in which cGMP controls chemotaxis through the action of myosin II, is too simplistic. Deletion of the gene for the myosin II heavy chain (mhcA) causes -amazingly -only a limited loss of motility; mhcA -cells grow at nearly normal rates, move at about half the speed of wild-type cells, and perform chemotaxis reasonably well considering their diminished speed [4] . (In most species, a failure in cytokinesis would be fatal, but Dictyostelium cells are able to compensate by 'traction-mediated cytofission', in which multinucleate cells literally tear themselves in two by causing different halves of the cell to walk in different directions.) The phenotypes of mutants with defects in guanylyl cyclase are different, however. Cells of KI-10, the strain in which guanylyl cyclase is decoupled from receptor activation, and KI-8, which exhibits almost no guanylyl cyclase activity, are completely unable to perform chemotaxis, despite apparently normal motility [5] . Chemotaxis must therefore require cGMP for more than just myosin II function. Also, it has recently been found that stmF phosphodiesterase mutant cells affect the motility of nearby wild-type cells [6] , which would not be expected if the cGMP-induced changes in motility are cell-autonomous. This work suggests that, as well as affecting myosin II, cGMP is also required for the transmission of signals from cells to their neighbours.
cGMP and osmosis
The role of cGMP in resisting osmotic forces appears to be far simpler. Kuwayama et al. [1] added 300 mM glucose to growing cells and followed the consequences. Within ten minutes of the onset of osmotic stress, wild-type cells changed from a typical flattened morphology to a rounded, rigid, non-motile form. The change in morphology correlated with a redistribution of myosin II from the rear of the cell and the pseudopodia to a uniform layer just below the actin-rich cortex (Fig. 1) . This result suggests that the cell protects itself from the forces imposed by a hyperosmotic medium by increasing its cortical tension, performing a slow squeeze which seems to considerably aid survival. After a 30 minute treatment with 300 mM glucose followed by redilution into buffer of low osmolarity, nearly all the wild-type cells survived, whereas only half the mhcA -cells were viable (although Kuwayama et al. [1] did not distinguish between cells dying during osmotic shock or following dilution). Furthermore, cells in which the heavy chain phosphorylation sites had been removed from myosin II survived as poorly as the mhcA -cells, even though the unphosphorylatable myosin is sufficient for nearly normal motility and cytokinesis.
The phosphorylation-dependent redistribution of myosin II is therefore a key part of the cell's defence against changes in the osmolarity of medium. It also correlates with a previously unknown, long-term increase in cGMP levels; peak concentrations are reached after 10 or more minutes, compared with the 10 second peak seen in response to chemoattractants. Kuwayama et al. [1] showed that KI-8 cells cannot alter cGMP in response to osmotic shock, and these cells also lose viability in hyperosmotic medium at a similar rate to mhcA -cells. The similar kinetics of cell death in the two strains suggest that in the osmotic response, unlike the chemotactic response, the sole effect of cGMP is on myosin II phosphorylation. In addition, the only missing component in KI-8 cells is cGMP: addition of the cell-permeant analogue 8-Br-cGMP in combination with glucose-containing medium restored survival to KI-8 cells, but did not assist mhcA -mutants.
Two-component systems and osmosis
Another well-known component of signalling pathways also turns out to be crucial for survival in high osmolarities. DokA, a recently identified gene [7] , is required for survival after osmotic shock. DokA -cells were found to survive the initial application of high-osmolarity medium, but to lyse as soon as they were diluted back to normal, low osmolarity conditions. This provides a plausible mechanism for osmoprotection by cGMP and myosin II. When cells move from high to low osmolarity, they suffer an inrush of water which produces an expansive force.
Amoebae have no cell walls, so they must use their cytoskeletons to resist the tendency to swell. The myosin II squeeze seems to be Dictyostelium's way of getting the best of both worlds: in a comfortable environment nothing obstructs the cell's movement, but under osmotic stress an actomyosin shell provides a de facto cell wall.
DokA encodes a homologue of bacterial histidine kinases fused to a response regulator domain. The bacterial proteins are known as 'two-component systems', because they consist of a histidine kinase whose activity is modulated by a sensor domain, along with a cognate response regulator. Activation of the sensor causes autophosphorylation of the histidine kinase, followed by transfer of the phosphoryl group to an aspartyl residue in the response regulator. The phosphorylation state of the response regulator controls downstream processes, such as movement and gene expression, in response to a wide range of environmental conditions, such as nutrient concentration, nitrogen availability, redox potential, and osmolarity. Previously thought to be specific to bacteria, two-component systems have recently been discovered in eukaryotes including Saccharomyces [8] , Arabidopsis [9] , and Dictyostelium; the latter apparently uses a separate two-component system, based around the dhkA histidine kinase [10] , to control spore formation. DokA resembles the yeast SLN1 gene [8] , which is also required for survival under unfavourable osmotic conditions. Both encode hybrid proteins in which both sensor and response regulator are fused -in other words, a 'one-component system'. However, unlike SLN1 or EnvZ (a similar osmosensor in Escherichia coli), dokA encodes nothing which resembles a membrane-spanning domain. Whatever factor it senses is therefore, presumably, intracellular.
The possible connections between the two newly discovered osmoregulatory systems are fascinating, and details will undoubtedly soon begin to emerge. The most intuitively likely pathway, in which dokA encodes the sensor which induces cGMP production in response to osmotic stress, was ruled out by Schuster and colleagues [7] , who found normal osmolarity-induced synthesis of cGMP in dokA -mutants. The converse -that dokA encodes the protein which couples the intracellular cGMP concentration to myosin II phosphorylation -would be unexpected. Two-component systems are usually the initial sensors of environmental conditions, not found halfway down the chain of command. This hypothesis is easily testable, as it predicts that dokA -mutants should lose the cGMP-mediated cringe and phosphorylation of myosin II seen in wild-type cells in response to chemoattractants. The effect on chemotaxis could be small, however: as discussed earlier, myosin II phosphorylation appears to be only a part of cGMP's contribution to the chemotaxis response. The other possible alternative is that the cGMP-myosin II and dokA pathways are independent, but both are necessary for resistance to osmotic shock. If this is the case, what is dokA doing to complement the osmotic squeeze?
